Correlation Between Biotechnology Ultrasector and Columbia Balanced

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biotechnology Ultrasector and Columbia Balanced at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biotechnology Ultrasector and Columbia Balanced into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biotechnology Ultrasector Profund and Columbia Balanced Fund, you can compare the effects of market volatilities on Biotechnology Ultrasector and Columbia Balanced and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biotechnology Ultrasector with a short position of Columbia Balanced. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biotechnology Ultrasector and Columbia Balanced.

Diversification Opportunities for Biotechnology Ultrasector and Columbia Balanced

0.67
  Correlation Coefficient

Poor diversification

The 3 months correlation between Biotechnology and Columbia is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Biotechnology Ultrasector Prof and Columbia Balanced Fund in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Columbia Balanced and Biotechnology Ultrasector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biotechnology Ultrasector Profund are associated (or correlated) with Columbia Balanced. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Columbia Balanced has no effect on the direction of Biotechnology Ultrasector i.e., Biotechnology Ultrasector and Columbia Balanced go up and down completely randomly.

Pair Corralation between Biotechnology Ultrasector and Columbia Balanced

Assuming the 90 days horizon Biotechnology Ultrasector Profund is expected to under-perform the Columbia Balanced. In addition to that, Biotechnology Ultrasector is 4.03 times more volatile than Columbia Balanced Fund. It trades about -0.19 of its total potential returns per unit of risk. Columbia Balanced Fund is currently generating about -0.13 per unit of volatility. If you would invest  5,550  in Columbia Balanced Fund on December 4, 2024 and sell it today you would lose (396.00) from holding Columbia Balanced Fund or give up 7.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Biotechnology Ultrasector Prof  vs.  Columbia Balanced Fund

 Performance 
       Timeline  
Biotechnology Ultrasector 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biotechnology Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's forward indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Columbia Balanced 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Columbia Balanced Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.

Biotechnology Ultrasector and Columbia Balanced Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biotechnology Ultrasector and Columbia Balanced

The main advantage of trading using opposite Biotechnology Ultrasector and Columbia Balanced positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biotechnology Ultrasector position performs unexpectedly, Columbia Balanced can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Columbia Balanced will offset losses from the drop in Columbia Balanced's long position.
The idea behind Biotechnology Ultrasector Profund and Columbia Balanced Fund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume